Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 57,497 | 21,988 | 21,973 | 59,276 | 39,700 |
| Cost of Goods | 6,676 | 6,483 | 6,509 | 15,566 | 3,610 |
| Gross Profit | 50,821 | 15,505 | 15,464 | 43,710 | 36,090 |
| Operating Expenses | 151,485 | 137,968 | 102,658 | 69,552 | 55,320 |
| Operating Income | -99,988 | -121,980 | -86,685 | -25,276 | -18,620 |
| Interest Expense | 11,932 | 11,859 | 2,657 | 281 | 280 |
| Other Income | 4,462 | 9,462 | 13,162 | 3,905 | -4,170 |
| Pre-tax Income | -107,458 | -124,377 | -76,180 | -21,652 | -23,070 |
| Net Income Continuous | -107,458 | -124,377 | -76,180 | -21,652 | -23,070 |
| Net Income | $-107,458 | $-124,377 | $-76,180 | $-23,215 | $-23,070 |
| EPS Basic Total Ops | -2.13 | -2.83 | -1.81 | -0.66 | -0.74 |
| EPS Basic Continuous Ops | -2.13 | -2.83 | -1.81 | -0.62 | -0.74 |
| EPS Diluted Total Ops | -2.13 | -2.83 | -1.81 | -0.66 | -0.74 |
| EPS Diluted Continuous Ops | -2.13 | -2.83 | -1.81 | -0.62 | -0.74 |
| EBITDA(a) | $-87,051 | $-113,526 | $-80,608 | $-20,855 | $-15,200 |